Cobrentin en es it fr

Cobrentin Brand names, Cobrentin Analogs

Cobrentin Brand Names Mixture

  • No information avaliable

Cobrentin Chemical_Formula


Cobrentin RX_link

Cobrentin fda sheet

Cobrentin msds (material safety sheet)

Cobrentin Synthesis Reference

No information avaliable

Cobrentin Molecular Weight

307.429 g/mol

Cobrentin Melting Point

No information avaliable

Cobrentin H2O Solubility

Very soluble

Cobrentin State


Cobrentin LogP


Cobrentin Dosage Forms


Cobrentin Indication

For use as an adjunct in the therapy of all forms of parkinsonism and also for use in the control of extrapyramidal disorders due to neuroleptic drugs.

Cobrentin Pharmacology

Benztropine is an anticholinergic used in the symptomatic treatment of all etiologic groups of parkinsonism and drug induced extrapyramidal reactions (except tardive dyskinesia). Benztropine possesses both anticholinergic and antihistaminic effects, although only the former has been established as therapeutically significant in the management of parkinsonism. Benztropine's anticholinergic activity is about equal to that of atropine.

Cobrentin Absorption

No information avaliable

Cobrentin side effects and Toxicity

Signs of overdose include confusion, nervousness, listlessness, hallucinations, dizziness; muscle weakness, ataxia, dry mouth, mydriasis, blurred vision, palpitations, tachycardia, elevated blood pressure, nausea, vomiting, dysuria, numbness of fingers, headache, delirium, coma, shock, convulsions, respiratory arrest, anhidrosis, hyperthermia, glaucoma, and constipation.

Cobrentin Patient Information

No information avaliable

Cobrentin Organisms Affected

Humans and other mammals